Christopher Richard Anzalone
Chief Executive Officer at Arrowhead Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arrowhead Pharmaceuticals Inc. March 12, 202594.7%
-
Arrowhead Pharmaceuticals Inc. March 14, 202496.6%
-
Arrowhead Pharmaceuticals Inc. March 16, 202396.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −7,416 | $65.88 | $488,566 |
| Jan 2, 2026 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −5,771 | $66.39 | $383,137 |
| Dec 29, 2025 | Arrowhead Pharmaceuticals Inc. | Option exercise | +35,181 | $6.15 | $216,363 |
| Dec 29, 2025 | Arrowhead Pharmaceuticals Inc. | Option exercise | +16,545 | $6.15 | $101,752 |
| Dec 29, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −35,181 | $69.33 | $2,439,099 |
| Dec 29, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −16,545 | $68.69 | $1,136,476 |
| Dec 22, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −10,012 | $68.33 | $684,120 |
| Dec 22, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −2,574 | $68.85 | $177,220 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −3,979 | $66.67 | $265,280 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −8,147 | $68.01 | $554,077 |
| Dec 19, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,319 | $68.48 | $90,325 |
| Dec 17, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −46,287 | $63.55 | $2,941,539 |
| Dec 17, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −35,750 | $64.51 | $2,306,233 |
| Dec 17, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −982 | $65.53 | $64,350 |
| Dec 17, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,981 | $66.30 | $131,340 |
Questions about Christopher Richard Anzalone
What boards is Christopher Richard Anzalone on?
Christopher Richard Anzalone sits on the board of Arrowhead Pharmaceuticals Inc.
What company is Christopher Richard Anzalone the CEO of?
Christopher Richard Anzalone is Chief Executive Officer of Arrowhead Pharmaceuticals Inc.
How long has Christopher Richard Anzalone served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.